Cardiopulmonary Exercise Testing Market Size, Share, Trends & Forecast
The Cardiopulmonary Exercise Testing Market is expanding as healthcare providers increasingly use exercise-based diagnostics to evaluate cardiovascular and pulmonary function. Market Research Future estimates that the market was valued at USD 0.96 billion in 2024 and is projected to reach USD 2.09 billion by 2035, registering a CAGR of 7.33% during 2025–2035.
Cardiopulmonary exercise testing (CPET) provides detailed information about how the heart, lungs, and muscles respond to physical activity. Its growing use in cardiovascular assessment, respiratory disease management, rehabilitation, and exercise physiology is supporting market expansion.
Technological advancements in sensors, metabolic carts, data analytics, and software are improving testing accuracy and efficiency. The increasing focus on preventive and personalized healthcare is also encouraging wider adoption.